Fifteen months on from completion of the BioNTech acquisition, co-founder and CEO Karim Beguir told TechCrunch in an interview that InstaDeep has made significant progress on that front ...

Fifteen months on from completion of the BioNTech acquisition, co-founder and CEO Karim Beguir told TechCrunch in an interview that Instadeep has made significant progress on that front, even as the ...

The options include the mRNA vaccines from Pfizer/BioNTech and Moderna — the vaccines that the ... of Arizona immunologist ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

With that, we look at the 10 Best Low Volatility Stocks to Invest in Now.

(Reuters) -Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround is succeeding after it reported a ...

Pfizer-BioNTech’s mRNA vaccine, Comirnaty ... We’re never going to get it perfect,” Bogoch told CTV News Toronto in an ...

Kennedy said in an interview Wednesday with NBC News that Trump has not ... Inc. (NYSE:PFE) down 3.9%, BioNTech SE ...

The options include the mRNA vaccines from Pfizer/BioNTech and Moderna — the vaccines ... Deepta Bhattacharya said of the guidance in an interview. “It doesn’t seem to be evidence-based ...

On Aug. 22, the Food and Drug Administration (FDA) approved the updated mRNA vaccines developed by pharmaceutical companies Moderna and Pfizer-BioNTech ... In a recent interview with MedPage ...

The chair of the national vaccination committee on the latest vaccine developments and the importance for vulnerable groups ...